- 英文名称
- Tandospirone citrate
- 分子式
- C27H37N5O9
- 分子量
- 575.61
- 中文别名
- 坦度螺酮柠檬酸盐; 柠檬酸坦度螺酮; REL-(3AR,4S,7R,7AS)-2-(4-(4-(嘧啶-2-基)哌嗪-1-基)丁基)六氢-1H-4,7-甲桥异吲哚-1,3(2H)-二酮 2-羟基丙烷-1,2,3-三羧酸盐; SM 3997; Methanospirone; Tandopsirone citrate; tandospirone dihydrogen citrate; Sediel; Sediel (TN); Tandospirone (citrate); (3aα,4β,7β,7aα)-Hexahydro-2-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-4,7-methano-1H-isoindole-1,3(2H)-dione·citric acid; 4,7-Methano-1H-isoindole-1,3(2H)-dione, hexahydro-2-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-, (3aa,4b,7b,7aa)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1); 4,7-Methano-1H-isoindole-1,3(2H)-dione, hexahydro-2-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-, (3aR,4S,7R,7aS)-rel-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) (9CI); 3aalpha,4alpha,5,6,7alpha,7aalpha-Hexahydro-2-[4- [4-(2-pyriMidinyl)-1-piperazinyl]butyl]-4,7-Methano-1H-isoindole-1,3(2H)-dione dihydrogen citrate; (1R,2S,6R,7S)-4-{4-[4-(Pyrimidin-2-yl)piperazin-1-yl]butyl}-4-azatricyclo[5.2.1.0]decane-3,5-dione 2-hydroxypropane-1,2,3-tricarboxylate (1:1); (1R,2S,6R,7S)-4-{4-[4-(2-Pyrimidinyl)-1-piperazinyl]butyl}-4-azatricyclo[5.2.1.0]decane-3,5-dione 2-hydroxy-1,2,3-tricarboxylate (1:1); 4,7-Methano-1H-isoindole-1,3(2H)-dione, hexahydro-2-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-, (3aR,4S,7R,7aS)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) (salt); 4,7-Methano-1H-isoindole-1,3(2H)-dione,hexahydro-2-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-,(3aalpha,4beta,7beta,7aalpha)-,2-hydroxy-1,2,3-propanetricarboxylate (1:1); metanopirone citrate; (3aR,4S,7R,7aS)-2-{4-[4-(pyrimidin-2-yl)piperazin-1-yl]butyl}hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione 2-hydroxypropane-1,2,3-tricarboxylate (1:1)
- 用途
- - 抗焦虑药
枸橼酸坦度螺酮为第三代新型抗焦虑药，由日本住友制药研制成功，主要作用于大脑边缘系统，对5-HT1A受体具有高度选择性，通过抑制5-HT神经冲动亢进，产生抗焦虑和抗抑郁作用。无依赖、无镇静、肌肉松弛、运动抑制等副作用，具有较好的临床药理特性。适用于各种神经症所致的焦虑状态，如广泛性焦虑症。原发性高血压、消化性溃疡等躯体疾病伴发的焦虑状态。
- 生物活性
Tandospirone citrate (SM-3997 citrate) 是一种有效的，选择性5-HT1A 受体激动剂 (Ki = 27 nM) , 比作用于 SR-2, SR-1C, α1, α2, D1 和D2受体选择性高(Ki值为1300-41000 nM)。
